LIPA and metabolic dysfunction-associated steatotic liver disease: We have used MR spectroscopy to characterize the lipid content and composition in LAL deficient and NAFLD patients, and in livers from LAL deficient, NAFLD, wild type and sebelipase alfa-treated LAL deficient rats.